Quadrant Private Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$247K Buy
+325
New +$246K 0.03% 272
2024
Q1
– Sell
-267
Closed -$235K – 243
2023
Q4
$235K Hold
267
– – 0.07% 196
2023
Q3
$220K Buy
+267
New +$210K 0.07% 195
2023
Q2
– Sell
-272
Closed -$223K – 252
2023
Q1
$223K Buy
+272
New +$205K 0.07% 219

Other funds holding REGN

Quadrant Private Wealth Management's REGN Position: Q3 2026 in Review

Quadrant Private Wealth Management opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 325 shares worth $247K. The stake represents 0.03% of the portfolio and ranks #272 among its holdings. This is a return to the name: Quadrant Private Wealth Management previously reported a position in REGN as recently as Q4 2023.

Quadrant Private Wealth Management first reported a position in REGN in Q1 2023 and has held it in 4 quarters since. 1,425 funds tracked by Wall St. Rank hold REGN as of Q3 2026.

  • Quadrant Private Wealth Management held 325 shares of Regeneron Pharmaceuticals worth $247K as of Q3 2026.
  • Regeneron Pharmaceuticals was a new Quadrant Private Wealth Management position in Q3 2026.
  • Regeneron Pharmaceuticals made up 0.03% of Quadrant Private Wealth Management's portfolio in Q3 2026, its #272 holding.
  • Quadrant Private Wealth Management first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
  • 1,425 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.

Based on Quadrant Private Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.